147 related articles for article (PubMed ID: 9482787)
1. A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine.
Janumpalli S; Butler LS; MacMillan LB; Limbird LE; McNamara JO
J Neurosci; 1998 Mar; 18(6):2004-8. PubMed ID: 9482787
[TBL] [Abstract][Full Text] [Related]
2. Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development.
Gellman RL; Kallianos JA; McNamara JO
J Pharmacol Exp Ther; 1987 Jun; 241(3):891-8. PubMed ID: 2885413
[TBL] [Abstract][Full Text] [Related]
3. Norepinephrine inhibits neurons of the intermediate subnucleus of the lateral septum via alpha2-adrenoceptors.
Liu W; Alreja M
Brain Res; 1998 Sep; 806(1):36-54. PubMed ID: 9739104
[TBL] [Abstract][Full Text] [Related]
4. Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice.
Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 1999 Jul; 290(1):403-12. PubMed ID: 10381806
[TBL] [Abstract][Full Text] [Related]
5. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine release from spinal synaptosomes: auto-alpha2 -adrenergic receptor modulation.
Li X; Zhao Z; Pan HL; Eisenach JC; Paqueron X
Anesthesiology; 2000 Jul; 93(1):164-72. PubMed ID: 10861160
[TBL] [Abstract][Full Text] [Related]
7. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine.
Franowicz JS; Kessler LE; Borja CM; Kobilka BK; Limbird LE; Arnsten AF
J Neurosci; 2002 Oct; 22(19):8771-7. PubMed ID: 12351753
[TBL] [Abstract][Full Text] [Related]
8. A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
Trendelenburg AU; Klebroff W; Hein L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):117-30. PubMed ID: 11534851
[TBL] [Abstract][Full Text] [Related]
9. Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study.
Strazielle C; Lalonde R; Hébert C; Reader TA
Neuroscience; 1999; 94(1):287-304. PubMed ID: 10613519
[TBL] [Abstract][Full Text] [Related]
10. Alpha 2-adrenergic receptor subtypes: subtle mutation of the alpha 2A-adrenergic receptor in vivo by gene targeting strategies reveals the role of this subtype in multiple physiological settings.
MacMillan LB; Lakhlani P; Lovinger D; Limbird LE
Recent Prog Horm Res; 1998; 53():25-42. PubMed ID: 9769701
[TBL] [Abstract][Full Text] [Related]
11. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.
Stone LS; MacMillan LB; Kitto KF; Limbird LE; Wilcox GL
J Neurosci; 1997 Sep; 17(18):7157-65. PubMed ID: 9278550
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis.
Egli RE; Kash TL; Choo K; Savchenko V; Matthews RT; Blakely RD; Winder DG
Neuropsychopharmacology; 2005 Apr; 30(4):657-68. PubMed ID: 15602500
[TBL] [Abstract][Full Text] [Related]
13. Central hypotensive effects of the alpha2a-adrenergic receptor subtype.
MacMillan LB; Hein L; Smith MS; Piascik MT; Limbird LE
Science; 1996 Aug; 273(5276):801-3. PubMed ID: 8670421
[TBL] [Abstract][Full Text] [Related]
14. Noradrenergic mechanisms in hippocampal kindling with rapidly recurring seizures.
Kokaia M; Bengzon J; Kalén P; Lindvall O
Brain Res; 1989 Jul; 491(2):398-402. PubMed ID: 2569912
[TBL] [Abstract][Full Text] [Related]
15. Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304.
Cockcroft V; Frang H; Pihlavisto M; Marjamäki A; Scheinin M
J Neurochem; 2000 Apr; 74(4):1705-10. PubMed ID: 10737629
[TBL] [Abstract][Full Text] [Related]
16. G-protein activation by putative antagonists at mutant Thr373Lys alpha2A adrenergic receptors.
Wurch T; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1999 Feb; 126(4):939-48. PubMed ID: 10193774
[TBL] [Abstract][Full Text] [Related]
17. Expression of functional alpha2-adrenergic receptor subtypes in human corpus cavernosum and in cultured trabecular smooth muscle cells.
Traish AM; Moreland RB; Huang YH; Goldstein I
Recept Signal Transduct; 1997; 7(1):55-67. PubMed ID: 9285531
[TBL] [Abstract][Full Text] [Related]
18. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice.
Altman JD; Trendelenburg AU; MacMillan L; Bernstein D; Limbird L; Starke K; Kobilka BK; Hein L
Mol Pharmacol; 1999 Jul; 56(1):154-61. PubMed ID: 10385696
[TBL] [Abstract][Full Text] [Related]
19. The alpha 2-adrenoreceptor agonist clonidine suppresses seizures, whereas the alpha 2-adrenoreceptor antagonist idazoxan promotes seizures in amygdala-kindled kittens: a comparison of amygdala and pontine microinfusion effects.
Shouse MN; Langer J; Bier M; Farber PR; Alcalde O; Moghimi R; Richkind M; Szymusiak R
Epilepsia; 1996 Aug; 37(8):709-17. PubMed ID: 8764807
[TBL] [Abstract][Full Text] [Related]
20. alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice.
Matsumoto K; Mizowaki M; Thongpraditchote S; Murakami Y; Watanabe H
Pharmacol Biochem Behav; 1997 Mar; 56(3):417-22. PubMed ID: 9077577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
